ID

38845

Beschrijving

Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs; ODM derived from: https://clinicaltrials.gov/show/NCT00819741

Link

https://clinicaltrials.gov/show/NCT00819741

Trefwoorden

Versies (1)
  1. 09-11-19 09-11-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

9 november 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes NCT00819741

Engels

Eligibility Diabetes NCT00819741

1 Formulieren  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00819741
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed with type 2 diabetes
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
never taken oral antidiabetic drugs before
Beschrijving

Antidiabetics Oral Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0332197
hba1c greater than 8.5 %
Beschrijving

Hemoglobin A1c measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0474680
bmi (body mass index) less than or equal to 35 kg/m^2
Beschrijving

Body mass index

Datatype

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy to repaglinide, metformin, or any of the excipients in the medications
Beschrijving

Hypersensitivity Repaglinide | Hypersensitivity Suspected Repaglinide | Metformin allergy | Metformin allergy Suspected | Hypersensitivity Repaglinide Excipient | Hypersensitivity Suspected Repaglinide Excipient | Hypersensitivity Metformin Excipient | Hypersensitivity Suspected Metformin Excipient

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0246689
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0246689
UMLS CUI [3]
C0571648
UMLS CUI [4,1]
C0571648
UMLS CUI [4,2]
C0750491
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0246689
UMLS CUI [5,3]
C0015237
UMLS CUI [6,1]
C0020517
UMLS CUI [6,2]
C0750491
UMLS CUI [6,3]
C0246689
UMLS CUI [6,4]
C0015237
UMLS CUI [7,1]
C0020517
UMLS CUI [7,2]
C0025598
UMLS CUI [7,3]
C0015237
UMLS CUI [8,1]
C0020517
UMLS CUI [8,2]
C0750491
UMLS CUI [8,3]
C0025598
UMLS CUI [8,4]
C0015237
taken an investigational drug in another clinical trial within 4 weeks prior to this trial
Beschrijving

Study Subject Participation Status | Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
impaired liver function, defined as asat (aspartate aminotransferase) or alat (alanine aminotransferase) equal to or greater than 2 times upper normal limit
Beschrijving

Liver Dysfunction | Aspartate aminotransferase increased | Alanine aminotransferase increased

Datatype

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C0151904
UMLS CUI [3]
C0151905
have a clinically significant, active disease of the gastrointestinal, pulmonary, neurological, renal, genitourinary, and haematological systems
Beschrijving

Gastrointestinal Disease | Lung disease | Nervous system disorder | Kidney Disease | Disorder of the genitourinary system | Hematological Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0017178
UMLS CUI [2]
C0024115
UMLS CUI [3]
C0027765
UMLS CUI [4]
C0022658
UMLS CUI [5]
C0080276
UMLS CUI [6]
C0018939
severe uncontrolled or untreated hypertension (sitting diastolic blood pressure (bp) equal to or greater than 100 mmhg or systolic bp equal to or greater than 180 mmhg)
Beschrijving

Uncontrolled hypertension Severe | Severe hypertension untreated | Sitting diastolic blood pressure | Sitting systolic blood pressure

Datatype

boolean

Alias
UMLS CUI [1,1]
C1868885
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C4013784
UMLS CUI [2,2]
C0332155
UMLS CUI [3]
C1319894
UMLS CUI [4]
C1319893
impaired renal function
Beschrijving

Renal Insufficiency

Datatype

boolean

Alias
UMLS CUI [1]
C1565489
acute or chronic acidosis or if there are plans to have a radiographic material containing iodine
Beschrijving

Acidosis | Chronic acidosis | Radiographic contrast material Containing Iodine

Datatype

boolean

Alias
UMLS CUI [1]
C0001122
UMLS CUI [2]
C1735903
UMLS CUI [3,1]
C0009924
UMLS CUI [3,2]
C0332256
UMLS CUI [3,3]
C0021968
have a clinically significant, active cardiovascular disease, or decompensated heart failure
Beschrijving

Cardiovascular Disease | Decompensated cardiac failure

Datatype

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0581377
treatment with systemic corticosteroids within the past two months prior to screening
Beschrijving

CORTICOSTEROIDS FOR SYSTEMIC USE

Datatype

boolean

Alias
UMLS CUI [1]
C3653708
Terug naar het begin van de pagina

Similar models

Eligibility Diabetes NCT00819741

1 Formulieren
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00819741
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
diagnosed with type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Antidiabetics Oral Absent
Item
never taken oral antidiabetic drugs before
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Hemoglobin A1c measurement
Item
hba1c greater than 8.5 %
boolean
C0474680 (UMLS CUI [1])
Body mass index
Item
bmi (body mass index) less than or equal to 35 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Repaglinide | Hypersensitivity Suspected Repaglinide | Metformin allergy | Metformin allergy Suspected | Hypersensitivity Repaglinide Excipient | Hypersensitivity Suspected Repaglinide Excipient | Hypersensitivity Metformin Excipient | Hypersensitivity Suspected Metformin Excipient
Item
known or suspected allergy to repaglinide, metformin, or any of the excipients in the medications
boolean
C0020517 (UMLS CUI [1,1])
C0246689 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0246689 (UMLS CUI [2,3])
C0571648 (UMLS CUI [3])
C0571648 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0246689 (UMLS CUI [5,2])
C0015237 (UMLS CUI [5,3])
C0020517 (UMLS CUI [6,1])
C0750491 (UMLS CUI [6,2])
C0246689 (UMLS CUI [6,3])
C0015237 (UMLS CUI [6,4])
C0020517 (UMLS CUI [7,1])
C0025598 (UMLS CUI [7,2])
C0015237 (UMLS CUI [7,3])
C0020517 (UMLS CUI [8,1])
C0750491 (UMLS CUI [8,2])
C0025598 (UMLS CUI [8,3])
C0015237 (UMLS CUI [8,4])
Study Subject Participation Status | Investigational New Drugs
Item
taken an investigational drug in another clinical trial within 4 weeks prior to this trial
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Liver Dysfunction | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
impaired liver function, defined as asat (aspartate aminotransferase) or alat (alanine aminotransferase) equal to or greater than 2 times upper normal limit
boolean
C0086565 (UMLS CUI [1])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
Gastrointestinal Disease | Lung disease | Nervous system disorder | Kidney Disease | Disorder of the genitourinary system | Hematological Disease
Item
have a clinically significant, active disease of the gastrointestinal, pulmonary, neurological, renal, genitourinary, and haematological systems
boolean
C0017178 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
C0027765 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
C0080276 (UMLS CUI [5])
C0018939 (UMLS CUI [6])
Uncontrolled hypertension Severe | Severe hypertension untreated | Sitting diastolic blood pressure | Sitting systolic blood pressure
Item
severe uncontrolled or untreated hypertension (sitting diastolic blood pressure (bp) equal to or greater than 100 mmhg or systolic bp equal to or greater than 180 mmhg)
boolean
C1868885 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C4013784 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3])
C1319893 (UMLS CUI [4])
Renal Insufficiency
Item
impaired renal function
boolean
C1565489 (UMLS CUI [1])
Acidosis | Chronic acidosis | Radiographic contrast material Containing Iodine
Item
acute or chronic acidosis or if there are plans to have a radiographic material containing iodine
boolean
C0001122 (UMLS CUI [1])
C1735903 (UMLS CUI [2])
C0009924 (UMLS CUI [3,1])
C0332256 (UMLS CUI [3,2])
C0021968 (UMLS CUI [3,3])
Cardiovascular Disease | Decompensated cardiac failure
Item
have a clinically significant, active cardiovascular disease, or decompensated heart failure
boolean
C0007222 (UMLS CUI [1])
C0581377 (UMLS CUI [2])
CORTICOSTEROIDS FOR SYSTEMIC USE
Item
treatment with systemic corticosteroids within the past two months prior to screening
boolean
C3653708 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial